| Insideraktier | 73.232.600 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Epirus Biopharmaceuticals Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i EPRSQ / Epirus Biopharmaceuticals Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i EPRSQ / Epirus Biopharmaceuticals Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-05-31 | 2016-05-27 | 4 | Wyand Michael | EPRS | Restricted Stock Units | D | 280.000 | 280.000 | ||||||
| 2016-05-31 | 2016-05-27 | 4 | Shea Thomas A. | EPRS | Restricted Stock Units | D | 230.000 | 230.000 | ||||||
| 2016-05-31 | 2016-05-27 | 4 | Ticktin Robert | EPRS | Restricted Stock Units | D | 230.000 | 230.000 | ||||||
| 2016-05-31 | 2016-05-27 | 4 | Aurentz Vincent | EPRS | Restricted Stock Units | D | 230.000 | 230.000 | ||||||
| 2016-03-11 | 2016-02-27 | 4/A | Wyand Michael | EPRS | Common Stock | D | 2,8000 | -1.378 | -4 | 32.662 | ||||
| 2016-03-11 | 2016-02-27 | 4/A | Wyand Michael | EPRS | Common Stock | D | 2.608 | 34.040 | ||||||
| 2016-03-11 | 2016-02-27 | 4/A | Wyand Michael | EPRS | Common Stock | D | 1.044 | 31.432 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Wyand Michael | EPRS | Restricted Stock Units | D | -2.608 | 7.824 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Wyand Michael | EPRS | Restricted Stock Units | D | -1.044 | 0 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Wyand Michael | EPRS | Common Stock | D | 2,8000 | -1.379 | -4 | 32.661 | ||||
| 2016-03-01 | 2016-02-27 | 4 | Wyand Michael | EPRS | Common Stock | D | 2.608 | 34.040 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Wyand Michael | EPRS | Common Stock | D | 1.044 | 31.432 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Shea Thomas A. | EPRS | Restricted Stock Units | D | -3.073 | 9.217 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Shea Thomas A. | EPRS | Restricted Stock Units | D | -1.044 | 0 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Shea Thomas A. | EPRS | Common Stock | D | 2,8000 | -1.554 | -4 | 31.489 | ||||
| 2016-03-01 | 2016-02-27 | 4 | Shea Thomas A. | EPRS | Common Stock | D | 3.073 | 33.043 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Shea Thomas A. | EPRS | Common Stock | D | 1.044 | 29.970 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Munshi Amit | EPRS | Restricted Stock Units | I | -9.887 | 29.661 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Munshi Amit | EPRS | Restricted Stock Units | I | -1.519 | 0 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Munshi Amit | EPRS | Common Stock | I | 2,8000 | -4.305 | -12 | 177.083 | ||||
| 2016-03-01 | 2016-02-27 | 4 | Munshi Amit | EPRS | Common Stock | I | 9.887 | 181.388 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Munshi Amit | EPRS | Common Stock | I | 1.519 | 171.501 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Ticktin Robert | EPRS | Restricted Stock Units | D | -2.134 | 6.400 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Ticktin Robert | EPRS | Restricted Stock Units | D | -949 | 0 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Ticktin Robert | EPRS | Common Stock | D | 2.134 | 6.083 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Ticktin Robert | EPRS | Common Stock | D | 949 | 3.949 | ||||||
| 2015-12-22 | 2015-12-21 | 4 | Ticktin Robert | EPRS | Common Stock | D | 3,7205 | 3.000 | 11 | 3.000 | ||||
| 2015-12-21 | 2015-12-17 | 4 | Aurentz Vincent | EPRS | Common Stock | D | 3,4300 | 2.200 | 8 | 2.200 | ||||
| 2015-12-17 | 2015-12-16 | 4 | Munshi Amit | EPRS | Common Stock | I | 2,8000 | 8.270 | 23 | 169.982 | ||||
| 2015-12-16 | 2015-12-15 | 4 | Munshi Amit | EPRS | Common Stock | I | 2,8700 | 8.069 | 23 | 161.712 | ||||
| 2015-12-11 | 2015-12-09 | 4 | Aurentz Vincent Purchased by Spouse | EPRS | Common Stock | I | 3,8500 | 2.800 | 11 | 2.800 | ||||
| 2015-12-10 | 2015-12-09 | 4 | Munshi Amit | EPRS | Common Stock | I | 4,0700 | 13.190 | 54 | 153.643 | ||||
| 2015-11-10 | 2015-11-09 | 4 | Aurentz Vincent | EPRS | Non-Qualified Stock Option (Right to Buy) | D | 5,21 | 219.487 | 219.487 | |||||
| 2015-11-03 | 2015-11-03 | 4 | Shea Thomas A. | EPRS | Employee Stock Option (Right to Buy) | D | 1,30 | -28.926 | 20.662 | |||||
| 2015-11-03 | 2015-11-03 | 4 | Shea Thomas A. | EPRS | Common Stock | D | 1,3000 | 28.926 | 38 | 28.926 | ||||
| 2015-11-03 | 2015-11-02 | 4 | Ticktin Robert | EPRS | Employee Stock Option (Right to Buy) | D | 5,55 | 39.474 | 39.474 | |||||
| 2015-11-03 | 2015-11-02 | 4 | Shea Thomas A. | EPRS | Employee Stock Option (Right to Buy) | D | 5,55 | 56.842 | 56.842 | |||||
| 2015-11-03 | 2015-11-02 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 5,55 | 58.247 | 58.247 | |||||
| 2015-11-03 | 2015-11-02 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 5,55 | 199.537 | 199.537 | |||||
| 2015-09-22 | 2015-09-21 | 4 | Munshi Amit | EPRS | Common Stock | I | 6,1900 | 10.000 | 62 | 140.453 | ||||
| 2015-09-21 | 2015-09-18 | 4 | Munshi Amit | EPRS | Common Stock | I | 5,9860 | 10.000 | 60 | 130.453 | ||||
| 2015-09-14 | 2015-09-14 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | -4.538 | 2.269 | |||||
| 2015-09-14 | 2015-09-14 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | -4.209 | 3.880 | |||||
| 2015-09-14 | 2015-09-14 | 4 | Wyand Michael | EPRS | Common Stock | D | 1,0000 | 8.747 | 9 | 30.388 | ||||
| 2015-07-06 | 2015-07-02 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | -22.681 | 14.860 | |||||
| 2015-07-06 | 2015-07-02 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | -7.246 | 18.639 | |||||
| 2015-07-06 | 2015-07-02 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | -21.273 | 43.397 | |||||
| 2015-07-06 | 2015-07-02 | 4 | Munshi Amit | EPRS | Common Stock | D | 1,0000 | 51.200 | 51 | 120.453 | ||||
| 2015-06-08 | 2015-06-05 | 4 | DUYK GEOFFREY M | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6,39 | 9.000 | 9.000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | BUCHI J KEVIN | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6,39 | 9.000 | 9.000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | ROCKLAGE SCOTT M | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6,39 | 9.000 | 9.000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | CORRIGAN MARK | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6,39 | 9.000 | 9.000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | Hunter William L | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6,39 | 9.000 | 9.000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | McHugh Julie | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6,39 | 9.000 | 9.000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | Fu Daotian | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6,39 | 9.000 | 9.000 | |||||
| 2015-04-03 | 2015-04-02 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 8,40 | 20.000 | 20.000 | |||||
| 2015-03-02 | 2015-02-27 | 4 | Ticktin Robert | EPRS | Restricted Stock Units | D | 8.534 | 8.534 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Ticktin Robert | EPRS | Restricted Stock Units | D | 949 | 949 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Ticktin Robert | EPRS | Employee Stock Option (Right to Buy) | D | 10,53 | 65.006 | 65.006 | |||||
| 2015-03-02 | 2015-02-27 | 4 | Wyand Michael | EPRS | Restricted Stock Units | D | 10.432 | 10.432 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Wyand Michael | EPRS | Restricted Stock Units | D | 1.044 | 1.044 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 10,53 | 79.461 | 79.461 | |||||
| 2015-03-02 | 2015-02-27 | 4 | Shea Thomas A. | EPRS | Restricted Stock Units | D | 12.290 | 12.290 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Shea Thomas A. | EPRS | Restricted Stock Units | D | 1.044 | 1.044 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Shea Thomas A. | EPRS | Employee Stock Option (Right to Buy) | D | 10,53 | 93.609 | 93.609 | |||||
| 2015-03-02 | 2015-02-27 | 4 | Munshi Amit | EPRS | Restricted Stock Units | D | 39.548 | 39.548 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Munshi Amit | EPRS | Restricted Stock Units | D | 1.519 | 1.519 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 10,53 | 301.225 | 301.225 | |||||
| 2015-02-09 | 2015-02-06 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 5,0093 | -100.000 | -501 | 1.671.400 | ||||
| 2015-02-09 | 2015-02-05 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 4,9742 | -67.316 | -335 | 1.771.400 | ||||
| 2015-02-06 | 2015-02-04 | 4 | ROCKLAGE SCOTT M See Footnotes | EPRS | Common Stock | I | 5,0000 | 389.950 | 1.950 | 2.549.211 | ||||
| 2015-02-06 | 2015-02-04 | 4 | ROCKLAGE SCOTT M See Footnotes | EPRS | Common Stock | I | 5,0000 | 10.050 | 50 | 65.699 | ||||
| 2015-02-06 | 2015-02-04 | 4 | 5AM Partners III, LLC | EPRS | Common Stock | I | 5,0000 | 389.950 | 1.950 | 2.549.211 | ||||
| 2015-02-06 | 2015-02-04 | 4 | 5AM Partners III, LLC | EPRS | Common Stock | I | 5,0000 | 10.050 | 50 | 65.699 | ||||
| 2015-02-05 | 2015-02-04 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 4,9505 | -5.684 | -28 | 1.838.716 | ||||
| 2015-02-05 | 2015-02-03 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 4,9879 | -47.000 | -234 | 1.844.400 | ||||
| 2015-01-28 | 2015-01-26 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 6,4675 | -38.516 | -249 | 1.891.400 | ||||
| 2015-01-26 | 2015-01-23 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 6,2737 | -8.400 | -53 | 1.929.916 | ||||
| 2015-01-26 | 2015-01-22 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 6,2972 | -14.130 | -89 | 1.938.316 | ||||
| 2014-09-03 | 3/A | ROCKLAGE SCOTT M | EPRS | Common Stock | I | 55.649 | ||||||||
| 2014-09-03 | 3/A | ROCKLAGE SCOTT M | EPRS | Common Stock | I | 2.159.261 | ||||||||
| 2014-08-04 | 3 | Livzon MABPharm Inc. | EPRS | Common Stock | D | 31.320.470 | ||||||||
| 2014-08-04 | 3 | Livzon MABPharm Inc. | EPRS | Common Stock | D | 31.320.470 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 24.953.987 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 41.763.682 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 24.953.987 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 41.763.682 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 24.953.987 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 41.763.682 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4.374.171 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4.374.171 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2.270.559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2.270.559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4.374.171 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2.270.559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2.270.559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4.374.171 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2.270.559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2.270.559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4.374.171 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4.374.171 | ||||||||
| 2014-07-17 | 2014-07-15 | 4 | BUCHI J KEVIN | EPRS | Non-Employee Stock Option (Right to Buy) | D | 1,30 | 13.259 | 13.259 | |||||
| 2014-07-17 | 2014-07-15 | 4 | CORRIGAN MARK | EPRS | Common Stock | D | 11,8000 | -14.597 | -172 | 21.859 | ||||
| 2014-07-17 | 2014-07-16 | 4 | Hunter William L | EPRS | Non-Employee Stock Option (Right to Buy) | D | 11,48 | 13.259 | 13.259 | |||||
| 2014-07-17 | 2014-07-16 | 4 | McHugh Julie | EPRS | Non-Employee Stock Option (Right to Buy) | D | 11,48 | 13.259 | 13.259 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 7,40 | 86.448 | 86.448 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | 6.807 | 6.807 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | 8.089 | 8.089 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | 20.209 | 20.209 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Wyand Michael | EPRS | Common Stock | D | 21.641 | 21.641 | ||||||
| 2014-07-17 | 2014-07-15 | 4 | Shea Thomas A. | EPRS | Employee Stock Option (Right to Buy) | D | 7,40 | 93.608 | 93.608 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Shea Thomas A. | EPRS | Employee Stock Option (Right to Buy) | D | 1,30 | 49.588 | 49.588 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 7,40 | 332.694 | 332.694 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | 37.541 | 37.541 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | 25.885 | 25.885 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1,00 | 64.670 | 64.670 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Munshi Amit | EPRS | Common Stock | D | 69.253 | 69.253 | ||||||
| 2014-07-17 | 2014-07-16 | 4 | Ticktin Robert | EPRS | Employee Stock Option (Right to Buy) | D | 11,48 | 99.442 | 99.442 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Seth Kim | EPRS | Employee Stock Option (Right to Buy) | D | 7,40 | 94.138 | 94.138 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Seth Kim | EPRS | Employee Stock Option (Right to Buy) | D | 5,80 | 49.058 | 49.058 | |||||
| 2014-07-17 | 3 | COULTER JAMES G See Explanation of Responses | EPRS | No securities beneficially owned | I | 0 | ||||||||
| 2014-07-17 | 2014-07-15 | 4 | TPG Group Holdings (SBS) Advisors, Inc. See Explanation of Responses | EPRS | Common Stock | I | 22.239.223 | 22.239.223 | ||||||
| 2014-07-16 | 3 | DUYK GEOFFREY M | EPRS | No securities beneficially owned | D | 0 | ||||||||
| 2014-02-12 | 2014-02-10 | 4 | CORRIGAN MARK | ZLCS | Stock Option (Right to Buy) | D | 1,47 | 250.000 | 250.000 | |||||
| 2014-02-12 | 2014-02-10 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 250.000 | 364.567 | ||||||
| 2014-02-12 | 2014-02-10 | 4 | Renz Justin A | ZLCS | Common Stock | D | 250.000 | 250.000 | ||||||
| 2014-01-17 | 2014-01-15 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 1,6600 | -18.079 | -30 | 114.567 | ||||
| 2014-01-07 | 2014-01-03 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 1,2200 | -8.035 | -10 | 132.646 | ||||
| 2013-06-10 | 2013-06-06 | 4 | CRAWFORD SALLY | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,58 | 15.000 | 15.000 | |||||
| 2013-06-10 | 2013-06-06 | 4 | HAYDU FRANK | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,58 | 15.000 | 15.000 | |||||
| 2013-06-10 | 2013-06-06 | 4 | OSHEA WILLIAM J | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,58 | 15.000 | 15.000 | |||||
| 2013-06-10 | 2013-06-06 | 4 | Kauffman Michael | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,58 | 15.000 | 15.000 | |||||
| 2013-06-10 | 2013-06-06 | 4 | Hunter William L | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,58 | 15.000 | 15.000 | |||||
| 2013-01-17 | 2013-01-15 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 0,7700 | -112.850 | -87 | 844.090 | ||||
| 2013-01-07 | 2013-01-03 | 4 | CORRIGAN MARK | ZLCS | Stock Option (Right to Buy) | D | 0,76 | 500.000 | 500.000 | |||||
| 2013-01-07 | 2013-01-03 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 250.000 | 956.940 | ||||||
| 2013-01-07 | 2013-01-03 | 4 | Cole Jason | ZLCS | Stock Option (Right to Buy) | D | 0,76 | 280.000 | 280.000 | |||||
| 2013-01-07 | 2013-01-03 | 4 | Renz Justin A | ZLCS | Stock Option (Right to Buy) | D | 0,76 | 280.000 | 280.000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | CRAWFORD SALLY | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,76 | 15.000 | 15.000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | HAYDU FRANK | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,76 | 15.000 | 15.000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | OSHEA WILLIAM J | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,76 | 15.000 | 15.000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | Kauffman Michael | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,76 | 15.000 | 15.000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | Hunter William L | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,76 | 15.000 | 15.000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | Foley Todd | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0,76 | 15.000 | 15.000 | |||||
| 2012-02-29 | 2012-02-29 | 4 | Gallen Christopher C. | ZLCS | Common Stock | D | 350.000 | 1.842.986 | ||||||
| 2012-01-31 | 2012-01-27 | 4 | Cole Jason | ZLCS | Common Stock | D | 1,0900 | -2.420 | -3 | 15.086 | ||||
| 2012-01-27 | 2012-01-25 | 4 | CORRIGAN MARK | ZLCS | Non-Qualified Stock Option (right to buy) | D | 1,13 | 799.226 | 799.226 | |||||
| 2012-01-27 | 2012-01-25 | 4 | CORRIGAN MARK | ZLCS | Incentive Stock Option (right to buy) | D | 1,13 | 100.774 | 100.774 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Cole Jason | ZLCS | Non-Qualified Stock Option (right to buy) | D | 1,13 | 242.809 | 242.809 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Cole Jason | ZLCS | Incentive Stock Option (right to buy) | D | 1,13 | 107.191 | 107.191 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Renz Justin A | ZLCS | Non-Qualified Stock Option (right to buy) | D | 1,13 | 313.121 | 313.121 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Renz Justin A | ZLCS | Incentive Stock Option (right to buy) | D | 1,13 | 111.879 | 111.879 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Gallen Christopher C. | ZLCS | Non-Qualified Stock Option (right to buy) | D | 1,13 | 53.692 | 53.692 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Gallen Christopher C. | ZLCS | Incentive Stock Option (right to buy) | D | 1,13 | 271.308 | 271.308 | |||||
| 2012-01-19 | 2012-01-17 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 1,1400 | -68.105 | -78 | 706.940 | ||||
| 2009-12-23 | 3 | Hunter William L | CRXX | Common Stock | D | 68.268 | ||||||||
| 2009-12-22 | 3 | Gallen Christopher C. | CRXX | Common Stock | D | 2.218.024 | ||||||||
| 2009-12-22 | 3 | Snutch Terrance P. | CRXX | Common Stock | D | 716.114 | ||||||||
| 2009-12-22 | 3 | Snutch Terrance P. By the Snutch Family Trust | CRXX | Common Stock | I | 53.982 | ||||||||
| 2009-12-22 | 3 | Wright C. Eugene | CRXX | No securities are beneficially owned. | D | 0 | ||||||||
| 2009-12-22 | 3 | CORRIGAN MARK | CRXX | Common Stock | D | 68.268 | ||||||||
| 2009-12-22 | 3 | Foley Todd | CRXX | Common Stock | D | 0 | ||||||||
| 2009-12-22 | 3 | Richardson Hartley T By James Richardson & Sons, Limited | CRXX | Common Stock | I | 9.564.403 | ||||||||
| 2009-12-22 | 3 | Richardson Hartley T | CRXX | Common Stock | D | 68.268 | ||||||||
| 2006-06-05 | 3 | Kauffman Michael | CRXX | None | D | 0 | ||||||||
| 2006-01-25 | 3 | Cole Jason | CRXX | No Securities Beneficially Owned | D | 0 | ||||||||
| 2005-11-17 | 2005-11-15 | 4 | Canaan Equity Partners II LLC | CRXX | Common Stock | I | 7,0000 | 259.349 | 1.815 | 259.349 | ||||
| 2005-11-17 | 2005-11-15 | 4 | Canaan Equity Partners II LLC | CRXX | Common Stock | I | 7,0000 | 907.653 | 6.354 | 907.653 | ||||
| 2005-11-17 | 2005-11-15 | 4 | Canaan Equity Partners II LLC | CRXX | Common Stock | I | 7,0000 | 706.352 | 4.944 | 706.352 | ||||
| 2005-11-17 | 2005-11-15 | 4 | YOUNG ERIC A | CRXX | Common Stock | I | 7,0000 | 259.349 | 1.815 | 259.349 | ||||
| 2005-11-17 | 2005-11-15 | 4 | YOUNG ERIC A | CRXX | Common Stock | I | 7,0000 | 907.653 | 6.354 | 907.653 | ||||
| 2005-11-17 | 2005-11-15 | 4 | YOUNG ERIC A | CRXX | Common Stock | I | 7,0000 | 706.352 | 4.944 | 706.352 | ||||
| 2005-11-09 | 3 | Lessem Jan | CRXX | Common Stock, $0.001 par value | D | 36.714 | ||||||||
| 2005-11-09 | 3 | Lessem Jan Footnote | CRXX | Common Stock, $0.001 par value | I | 1.143 | ||||||||
| 2005-11-09 | 3 | Keith Curtis T | CRXX | Common Stock, $0.001 par value | D | 42.857 | ||||||||
| 2005-11-09 | 3 | Goldfield Jacob | CRXX | Common Stock, $0.001 par value | D | 2.857 | ||||||||
| 2005-11-09 | 3 | Goldfield Jacob | CRXX | Common Stock, $0.001 par value | D | 2.857 | ||||||||
| 2005-11-09 | 3 | Borisy Alexis | CRXX | Common Stock, $0.001 par value | D | 271.429 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
